Cite this article: Liu X et al. Mastitis costs the dairy industry billions of dollars annually and is the most consequential disease of dairy cattle. Transgenic cows secreting an antimicrobial peptide demonstrated resistance to mastitis. The combination of somatic cell gene targeting and nuclear transfer provides a powerful method to produce transgenic animals. Recent studies found that a precisely placed doublestrand break induced by engineered zinc-finger nucleases (ZFNs) stimulated the integration of exogenous DNA stretches into a pre-determined genomic location, resulting in high-efficiency site-specific gene addition. Here, we used ZFNs to target human lysozyme (hLYZ) gene to bovine b-casein locus, resulting in hLYZ knock-in of approximately 1% of ZFN-treated bovine fetal fibroblasts (BFFs). Gene-targeted fibroblast cell clones were screened by junction PCR amplification and Southern blot analysis. Gene-targeted BFFs were used in somatic cell nuclear transfer. In vitro assays demonstrated that the milk secreted by transgenic cows had the ability to kill Staphylococcus aureus. We report the production of cloned cows carrying human lysozyme gene knock-in b-casein locus using ZFNs. Our findings open a unique avenue for the creation of transgenic cows from genetic engineering by providing a viable tool for enhancing resistance to disease and improving the health and welfare of livestock.
Introduction
Zinc-finger nuclease (ZFN) technology has enabled efficient, site-specific gene modification in live cells [1] [2] [3] [4] . ZFNs can be engineered to introduce a doublestrand break (DSB) at a pre-determined site in the genome by combining the non-specific nuclease domain of the type IIS restriction enzyme FokI with an array of zinc-finger domains that bind in the major groove of DNA and recognize a desired DNA target site [5] . Each individual zinc-finger domain recognizes three to four contiguous base pairs. Typical ZFNs contain three to six zinc fingers recognizing 9-18 bp of DNA. Because FokI functions as a dimer, two ZFNs are designed to bind directly up-and downstream of the intended cleavage site, providing stringent recognition of a potentially unique site in the genome [6, 7] .
Lysozyme is an antimicrobial protein widely distributed in various biological fluids and tissues (including avian egg and animal secretions, and human milk, tears, saliva and airway secretions), and is secreted by polymorphonuclear (PMN) leucocytes [8] . The active role played by lysozyme in defence systems against bacterial infections to the epithelia of the respiratory organs and gastrointestinal tract has long been recognized [9, 10] . It has been reported that transgenic goats expressing human lysozyme in the mammary gland could improve udder health [11] .
Our objective was to design an efficient and reproducible gene-targeting system in BFFs by inserting the exogenous human lysozyme (hLYZ) gene into the b-casein locus with ZFNs and subsequently using the targeted cell clones as donor cells for somatic cell nuclear transfer (SCNT). Following this, human lysozyme protein might be produced in gene-targeted bovine mammary glands, and transgenic cows expressing human lysozyme in their milk are resistant to certain Gram-positive bacteria (e.g. Staphylococcus aureus) and, to a lesser degree, against Gram-negative bacteria infection. Because the success rate of SCNT is low (less than 2%) [12] , it is important to evaluate the tissue-specific expression of the transgenic constructs and to prepare competent transgenic donor cells prior to SCNT. Otherwise, if one transgenic construct is not expressed correctly, it will result in wasted surrogates, labour and increased costs to produce transgenic animals. However, few papers have described efficient procedures to estimate the tissue-specific expression of the transgene in vitro and to identify transgenic donor cell clones for SCNT. Here, our intent was to determine an effective procedure to prepare human lysozyme transgenic cells with ZFNs for SCNT that consists of evaluating the expression of transgenic constructs in bovine mammary epithelial cells (BMECs) in vitro and identifying competent transgenic fibroblast cell clones. This procedure could be prospectively applied to the production of other recombinant pharmaceuticals in transgenic cows by SCNT.
Results (a) Assessment of zinc-finger nuclease activity in bovine fetal fibroblasts
Different amounts of plasmids expressing ZFNs were cotransfected with pEGFP-C1 into BFFs (figure 1a). The frequency of ZFN-mediated disruption at the target site in each pool of cells was determined using the CEL-I nuclease assay. We found that the expression of ZFNs gradually enhanced targeted gene cleavage with increasing amounts of transfected plasmid, as demonstrated by the increased incidence of allelic mutation (non-homologous end joining (NHEJ) frequency) in the ZFNtreated pools, particularly at low levels of input ZFN (figure 1b,c).
To determine the molecular identity of the ZFN-mediated mutations in the b-casein gene (CSN2) easily and quickly, we amplified the CSN2 ZFNs target region from genomic DNA that was harvested 3 days after BFFs were transfected with ZFNs. PCR products corresponding to the targeted site were sequenced directly. As shown in figure 1d , the presence of multiple peaks after the target site in the sequencing curves clearly distinguishes mutants from non-targeted cells. Then, the PCR fragments were subcloned into the pMD19-T vector. The sequencing of this product revealed numerous molecularly distinct short deletions and insertions in 18.25% of sequence reads (23 out of 126 sequences; figure 1e). All of the identified mutations mapped to the core of the ZFN recognition site, suggesting that the permanent modifications to the CSN2 locus were the product of ZFN cleavage and subsequent repair via NHEJ. We found that the CEL-I nuclease assay underestimates ZFNs' cutting efficiency compared with the sequencing analysis. This is presumably because the CEL-I nuclease assay cannot detect alleles of the target locus that introduce the same base insertion or deletion.
(b) Efficient zinc-finger nuclease-induced hLYZ integration into the CSN2 locus in bovine fetal fibroblasts
To investigate the efficient ZFN-induced exogenous gene integration into a native chromosomal locus, we introduced the targeting vector pCSN2-hLYZ-Neo-GFP (electronic supplementary material, figure S1 ) into BFFs along with expression plasmids encoding designed ZFNs that were engineered to introduce a DSB in intron 2 of CSN2 (figure 2a). After 72 h of culturing the cells in normal medium and in the absence of any selection, we harvested genomic DNA and measured the integration of the exogenous gene by junction PCR. As expected, no measurable exogenous gene integration into the chromosome was observed in the absence of ZFNs. By contrast, the junction region between endogenous and exogenous DNA was amplified by primers P1 and P2 in cells that were exposed both to the donor plasmid and ZFNs (figure 2b; lane 4). BFFs were co-transfected with pCSN2-hLYZ-Neo-GFP and the ZFN expression plasmids pZFN1/2 or an 'empty' control vector. Stably transduced cells that were present in target cell populations were identified following 7-9 days of (600 mg ml 21 ) G418 selection. Stably transfected cell clones were digested using trypsin and transferred to a 48-well plate and cultured for PCR detection. However, the cultures derived from the pZFN1/2-transfected cells contained more stably transduced cells than those derived from BFFs that were not exposed to the ZFN expression plasmids (table 1) .
We next asked whether the stable genetic modification of cells in each of these experimental groups resulted from targeted or random DNA insertion. To this end, drug-resistant colonies from the two different set-ups were trypsinized and screened for targeted events by PCR. Five microlitres of the DNA lysate was then used for 5 0 junction PCR analysis with primers P1 and P2, specific for the CSN2 locus and the human lysozyme cDNA, respectively (figure 2a). Parental, non-transfected BFFs served as a negative control. Homology-directed gene targeting at CSN2 following transfection of pCSN2-hLYZ-Neo-GFP should produce a 1281-bp PCR fragment (figure 2c). Products with a size that was consistent with this process could readily be detected in 15.88% (n ¼ 529) of PCR samples, corresponding to DNA of cell clones derived from parental primary culture BFFs that were exposed to pCSN2-hLYZ-Neo-GFP and pZFN1/2 ( ), the PCR assay that was performed on DNA of cell clones derived from pCSN2-hLYZNeo-GFP-positive cells did not receive the ZFN expression plasmids yielded non-specific amplification products (n ¼ 125; table 1). To rule out potential false positives, we used 3 0 junction PCR on genomic DNA from 5 0 junction PCR-positive colonies with primers P3 and P4 to amplify the right-hand junction between endogenous and exogenous DNA (figure 2d). We found that 15.8% (84) of the G418-resistant colonies contained correctly targeted cells (table 1) . Many targeted colonies also contained non-targeted cells and a few targeted colonies senesced before they could be prepared for nuclear transfer. The karyotype of each colony was checked; all had chromosome numbers in a range similar to that of freshly isolated BFF cells (%80% of spreads with 60 chromosomes). Finally, 16 colonies were available for selecting a clonal targeted population with a stable karyotype that could be expanded for nuclear transfer (table 1) .
We identified the eight most likely off-target sites in the bovine genome that are most similar to the CSN2 target site for unwanted modification of the gene-targeted cell colonies that were suitable for NT (electronic supplementary material, table S1). To validate the specificity of the CSN2 ZFNs, we tested the eight most likely off-target sites in all 16 genetargeted cell colonies using mutation detection assay. None of the 16 gene-targeted cell colonies had an NHEJ event at the eight most likely off-target sites. However, we detected that the eighth most positive cell clone has a random integration at the off-target site ZF385D and the inserted fragment size is about 8700 bp (electronic supplementary material, figure S2 ). 
(d) Somatic cell nuclear transfer and cloned transgenic cow production
Gene-targeted cloned embryos were produced from bovine oocytes of ovaries collected from slaughtered cows. The cumulus-oocyte complexes were cultured and matured in vitro for 22-24 h, and the percentage of oocytes that underwent germinal vesicle breakdown and progressed to metaphase II was 71.0% (1336/1881). Three cell lines from the six targeted colonies suitable for NT were selected as donor cells. A total of 1147 fused embryos were obtained, and NT-cloned embryos derived from bovine fetal cells that were transfected in vitro developed following NT using in vitro-matured oocytes (table 2 and figure 3a) . To rule out mixed colonies (many targeted colonies also contained non-targeted cells), 10 NT-cloned embryos were used for individual-embryo lysates. Embryo lysate was then used for 5 0 junction PCR analysis using primers P1 and P2, and long-range PCR analysis using primers P5 and P6. PCR analysis showed that the 10 embryos were all heterozygous for the human lysozyme gene knock-in at the b-casein locus, and thus would have one normal copy and one targeted copy of the b-casein gene ( figure 3b ). This result firmly demonstrated that the targeted colonies we isolated did not contain non-targeted cells. These developed cloned embryos were transferred to 118 recipient cows, and 46 recipients did not return to oestrous. Among them, 20 cows were pregnant at day 90, and finally, five transgenic calves were born (table 2 and figure 3c).
(e) Analysis of cloned cows
Tissue was recovered from the cloned cows for both junction PCR and Southern blot analysis. The two junction PCR screens for each locus revealed patterns consistent with targeting (figure 4a) in all the targeted samples that were recovered. In Southern blot analyses, both 5 0 (external) and hLYZ coding sequence (internal) probes hybridized to restrict fragments of the correct size. The location of probes and restriction sites is figure 4b . These data show that cows carrying targeted gene additions can be generated by nuclear transfer. To produce milk containing human lysozyme from transgenic cows in the context of the original composition without any changes, we did not deliberately select homozygous integrants. We used the single-cell-derived clones that were all heterozygous for the human lysozyme gene knock-in at the b-casein locus for NT and finally obtained gene-targeted calves. Milk samples from transgenic and non-transgenic cow were collected each month for six months during their natural lactation period. There were no significant differences in milk yield and percentage of fat, protein, lactose and milk solids in the milk of transgenic and non-transgenic cows, as given in table 3. Milk proteins of the transgenic cows, as visualized on a polyacrylamide gel, appeared essentially identical to those from a non-transgenic cow (electronic supplementary material, figure S4) . A single protein of predicted size was immunologically reactive to antibodies against human lysozyme. The protein was observed in the milk from five transgenic cows during their first lactations, but not in the milk of non-transgenic cows (figure 4c). Human lysozyme concentrations, as measured by enzyme-linked immunosorbent assay (ELISA), ranged from 23 to 31 mg ml 21 in five transgenic cows (figure 4d). Milk from transgenic cows was tested against a variety of microorganisms; some inhibition of growth was observed when lawns of Sta. aureus, Escherichia coli or Streptococcus agalactiae were exposed to milk from transgenic cows or to recombinant human lysozyme (figure 4e). The transgenic cows' ability to resist infection by Sta. aureus, E. coli or Str. agalactiae was tested by intra-mammary infusion of viable bacterial cultures. Of the mammary glands infused, 19 of 20 glands became infected in non-transgenic animals compared with 0 of 20 glands in transgenic animals (table 4) .
A primary clinical indicator of mastitis is an elevation in milk somatic cells (mainly PMN neutrophil leucocytes and macrophages). Twelve hours after the infusion of mammary glands with Sta. aureus, E. coli or Str. agalactiae, somatic cells in milk increased in non-transgenic animals but not in transgenic animals (figure 4f ). Both lipopolysaccharide-binding protein (LBP) and serum amyloid A (SAA) also serve as a measure of a systemic response to infection [13] [14] [15] . Increased levels of LBP and SAA were detected in the non-transgenic animals. By contrast, the transgenic cows had no demonstrable changes in the levels of either of these acute-phase proteins (electronic supplementary material, figure S5 ).
Discussion
Transgenic animals with specific modifications can be generated by many techniques, such as direct injection of exogenous DNA to a fertilized pronucleus, gene targeting and NT. Transgenic animal mammary gland bioreactors are desired for the production of recombinant protein for medical purposes [16] [17] [18] [19] . Mammary gland production of antibacterial proteins for enhanced mastitis resistance has been proposed as a prime agricultural application of this technology [15, [20] [21] [22] . However, it is very difficult to raise the product level in the mammary gland by injecting exogenous DNA that is integrated randomly into the animal genome. The injected exogenous DNA usually shows a very low integration rate in the genomic DNA, and integration is required for the exogenous gene to be expressed at an appropriate level. So far, the problem might be solved by NT, and transgenic domestic animals have been produced by cloning gene-transfected somatic cells in sheep [23] , cattle [24] and goats [25] . Based on animal cloning techniques, gene-targeted sheep and pigs have been rspb.royalsocietypublishing.org Proc. R. Soc. B 281: 20133368 cloned successfully [26] [27] [28] [29] . Here, we established a method for gene targeting of BFFs using engineered ZFNs. Using gene-targeted cell lines as donor cells for NT, a total of 1147 fused embryos were obtained, 363 embryos developed to the blastocyst stage, 236 Grade I blastocysts were transferred to 118 recipient Angus cows (two blastocysts/recipient), with 20 cows pregnant at day 90 and five gene-targeted calves were born (table 2 and figure 3c).
Transgenic goats expressing the human lysozyme gene have been produced and extensively characterized [11] . However, the technology that was used then was simply the random integration of the transgene that contained human lysozyme gene under control of the bovine a S1 -casein promoter. We report a new technology that enables the production of precisely engineered transgenic cows. We have successfully inserted the human lysozyme gene into the b-casein gene locus of cows. Bovine milk typically contains only 0.05-0.22 mg ml 21 of lysozyme [30] . In addition, its activity is 1/10 of lysozyme from human breast milk [31, 32] . When these cows lactated, the milk contained both bovine and human lysozymes that had stronger antibacterial activity than non-transgenic cows. This represents a step towards the eventual FDA approval of transgenic animals because the transgene can be inserted into a pre-defined locus.
Here, we attempted to establish an effective and reliable procedure to prepare gene-targeted somatic cells that could be used for the production of transgenic mammary gland bioreactors by SCNT. Thus, two types of cell culture systems were established: (i) inductive expression of exogenous transgenes in BMECs in vitro and (ii) gene-targeted fibroblast cell clones used as donor cells for SCNT. Mammary epithelial [33] . Therefore, to examine the availability of lysostaphin transgenic expression in vitro, BMECs were stimulated with hormone signals (insulin, prolactin plus hydrocortisone). BMECs might be a useful model to evaluate transgenic expression in vitro before SCNT, which could markedly reduce the probability of the transgene being silenced in offspring and lower the cost of producing transgenic animals [34, 35] .
In conclusion, an effective procedure to prepare transgenic donor cells by gene targeting for SCNT was established. We believe that our results demonstrate the feasibility of using genetic engineering to introduce beneficial genes into cows. Such transgenes could have a positive impact on the economics of the dairy industry and on animal welfare.
Material and methods (a) Zinc-finger nuclease and donor DNA constructs
ZFNs were designed and assembled as previously described [1, 2] . Their ability to bind to their target DNA sites in vitro was determined using an ELISA-based assay as previously described [3] . ZFNs targeting intron 2 of the bovine CSN2 gene used in this study are available through Sigma-Aldrich (St. Louis, MO; lot number: 08181029MN).
The b-casein targeting vector ( pCSN2-hLYZ-Neo-GFP) was constructed by PCR to amplify a 1.4 kb homology arm of b-casein (AC_000163). This 1.4 kb homology arm contained the ZFN-binding site (5 0 -TTCATCCACTATCTCAGTagtatCCTATGG GACCACAAG-3 0 ) and was cloned into the pMD19-T vector (Takara). The unique ZFN cut site (5 0 -AGTAT-3 0 ) in the centre of the ZFN-binding site was converted into a NotI site (5 0 -GCGG CCGC-3 0 ) to construct the vector pTCSN2, and the exogenous human lysozyme gene and marker genes were inserted into the NotI site of pTCSN2 using standard recombinant DNA techniques.
The expression plasmid pEGFP-C-hLYZ was constructed by inserting the human lysozyme gene sequence into the multiple cloning site of pEGFP-N1. Corresponding sequences (b-casein ATG first exon-partial intron 2 and b-casein ATG first exon-partial intron 2-splice acceptor-human lysozyme gene sequence) were generated by PCR from plasmid pCSN2-hLYZ-Neo-GFP and subcloned into the vector pEGFP-N1 to construct pEGFP-S-hLYZ. The plasmid pEGFP-I-hLYZ was constructed by subcloning the corresponding sequences (splice acceptor-human lysozyme gene sequence-EGFP sequence-SV40 Ploy A sequence) from plasmid pEGFP-S-hLYZ to the NotI site of pTCSN2.
(b) Cell culture and selection
Primary fetal bovine fibroblasts were isolated from 35-day-old fetuses. The cells were trypsinized and frozen in 50% FBS (GIBCO; lot number: 623311), 40% media and 10% DMSO (Sigma; lot number: 74396HMV), for long-term storage and future use. When needed, cells were placed in a 4 mm gap cuvette with 10 mg of the targeting vector (pCSN2-hLYZ-Neo-GFP) and 5 mg of the ZFNs-encoding plasmids, and electroporated at 510 V with three pulses of 1 ms duration using the BTX Electro-cell manipulator ECM2001. Electroporated cells were mixed with fresh cell culture medium and plated on 10 cm plates at 5 Â 10 5 cells per plate. Three days later, cells were placed in culture medium containing 600 mg ml 21 G418 (Sigma; lot number: 091M1287 V) for 6 days. Cell clones were then collected for PCR screening. 
(d) Western blot analysis
Mammary epithelial cells expressing green fluorescent protein were lysed and centrifuged, and the supernatants were boiled in SDS sample buffer for 5 min and separated by SDS-PAGE on a 12% polyacrylamide gel. 
(e) Nuclear transfer
SCNT procedures were performed as described previously [36] . Fresh day 7 blastocysts were non-surgically transferred (two embryos per recipient) to the ipsilateral uterine horn of Angus Table 4 . Infection rate of three types of bacterium infused into mammary glands of five transgenic and five non-transgenic lactating cows. During each challenge experiment, each gland was infused with one of the three types of bacterium and the fourth gland was infused with PBS. TG, transgenic cows; WT, non-transgenic cows. rspb.royalsocietypublishing.org Proc. R. Soc. B 281: 20133368 recipients on day 7 of standing oestrous. Pregnancy was detected by rectal palpation/ultrasonography at 90 days of gestation.
(f ) Southern blot analysis
Calf ear biopsies were lysed overnight at 608C in a shaking incubator with approximately 1 ml lysis solution (50 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 10 mM EDTA, 1% SDS, 25% sodium perchlorate, 1% 2-mercaptoethanol and 200 mg ml 21 proteinase K) per 150 mg tissue. DNAwas subjected to phenol/chloroform extraction and precipitated with isopropyl alcohol. Following electrophoresis, DNA was transferred to a nylon membrane and probed a 3 0 -end digoxigenin-labelled probe. The probe locations are shown in figure 2a. Bands were detected using a chemiluminescent substrate system.
(g) Milk sample collection
Milk was either collected from an automated sampling device during the normal process of milking or collected by hand in an aseptic manner. All samples were centrifuged at 800g for 15 min at 48C, and the infra-natant was collected and tested immediately or frozen at 2208C until use.
(h) Bacterium mammary gland challenge
Forty-eight hours before initiating the bacterial challenges, the health of the animals was assessed by differential leucocyte and milk somatic cell counts to verify that they were within normal ranges. After the morning milking, an aseptic milk sample was collected from each of the four glands before infusing 2 ml of three different strains of bacterium (one per gland) via the streak canal. The fourth gland received 2 ml of sterile PBS. Milk samples (20 ml) were plated on blood agar and incubated at 378C for 18 -24 h. Once an infection was confirmed by the presence of viable bacterium in two consecutive milk samples, all four quarters were treated with 10 ml of pirlimycin hydrochloride (Pfizer) for five consecutive milkings.
(i) Statistical analysis
Each experiment was performed at least three times. All data were analysed using SPSS 20.0 statistical software (IBM Corporation, Somers, NY). Data were tested by one-way ANOVA and least-significant-difference tests, and reported as the mean + s.e.m. For all analyses, p , 0.05 was considered significant. All experiments were approved by the Care and Use of Animals Center, Northwest A&F University. This study was carried out in strict accordance with the Guidelines for the Care and Use of Animals of Northwest A&F University.
